The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R43/R44)
Letter of Intent Due Date(s): 30 days prior to the application due date
Application Due Date(s): February 20, 2015 (Phase I or Fast-Track); February 20, 2016 (Phase I; Phase II; or Fast-Track); February 20, 2017 (Phase II only)
RFA-HL-15-030 Expiration Date New Date July 21, 2017 per issuance of NOT-HL-16-464. (Original Expiration Date: February 21, 2017)